Dominion Diagnostics Executive and Leadership Team

Robert Garvey, the Chief Executive Officer at Dominion Diagnostics, directs the overarching strategic vision for clinical laboratory operations. Garvey architects long-term growth initiatives while ensuring the organization maintains high standards in drug monitoring solutions. By aligning laboratory capabilities with the evolving needs of behavioral health and primary care providers, the Chief Executive Officer drives market expansion across the United States. This leadership role involves constant collaboration with the Board to refine diagnostic service offerings and improve patient outcomes through precise medication management data. Robert Garvey monitors industry trends to maintain a competitive edge in the diagnostic testing sector. Through rigorous oversight of corporate objectives, the Chief Executive Officer secures the financial and operational health of the enterprise. Ultimately, Garvey fosters a culture of clinical excellence that supports healthcare systems in managing complex patient therapies effectively and reliably.

Mark Peters, the Chief Financial Officer at Dominion Diagnostics, manages the fiscal health and capital allocation strategies for the clinical laboratory. Peters oversees financial planning, budgeting, and reporting processes to ensure the sustainability of diagnostic testing services. By analyzing revenue streams from medication management programs, the Chief Financial Officer optimizes resource distribution across hospital systems and primary care networks. This role requires close coordination with executive leadership to evaluate investment opportunities in laboratory technology and infrastructure. Mark Peters maintains rigorous internal controls to support the integrity of financial operations. Through strategic forecasting, the Chief Financial Officer mitigates fiscal risks while identifying avenues for sustainable growth. By balancing operational costs with the demand for high-quality diagnostic data, Peters ensures the company remains a leader in the health services sector, providing consistent value to healthcare providers and stakeholders alike.

Dave Senerchia, the Chief Financial Officer & Executive VP, Business Development at Dominion Diagnostics, drives revenue growth through strategic partnerships and market expansion. Senerchia architects business development initiatives that connect the laboratory with new hospital systems and primary care networks. As a financial leader, the Chief Financial Officer & Executive VP, Business Development evaluates the profitability of new service lines and monitors the financial impact of expanded diagnostic testing capabilities. This role involves identifying emerging opportunities in medication management to broaden the company's reach across the United States. Dave Senerchia collaborates with the executive team to align business development goals with long-term fiscal objectives. By leveraging market insights, the Chief Financial Officer & Executive VP, Business Development secures new contracts and strengthens existing provider relationships. Through disciplined financial management and aggressive growth strategies, Senerchia ensures the company maintains a dominant position in the clinical diagnostics market.

Mark McSally, the Chief Operating Officer & General Counsel at Dominion Diagnostics, directs the daily laboratory workflows and legal compliance frameworks. McSally architects efficient operational processes that support the delivery of drug monitoring solutions to behavioral health and psychiatry practices. As General Counsel, the Chief Operating Officer & General Counsel manages regulatory adherence and contractual obligations, ensuring all diagnostic testing services meet stringent healthcare standards. This dual-function role involves streamlining internal logistics to enhance the speed and accuracy of clinical information provided to healthcare systems. Mark McSally coordinates with department heads to resolve operational bottlenecks and mitigate legal exposure. By integrating legal precision with operational excellence, the Chief Operating Officer & General Counsel drives the scalability of laboratory services. Through this comprehensive approach, McSally ensures the organization maintains robust performance metrics while navigating the complex regulatory landscape of the diagnostic industry.